US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug - Reuters
US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxNV2FXR19tUWxiQ2RMdWp5SHJZUFlpSEUtamdIMXdReTd4UzV0Zm0xODZCeGE0bEt4Nmd2MVV6akl6OGtQdVVwNTlEczIwcHVhVGNHVVplMUROQUZoUTFKcHI1ajY1Y3UydGZsZGtsM3duc3BDeDlWQl9LaGtaNFgtMk1LbWcwTXlkVEpIOEMtTGppOTFJMVBPX3RnS0xOaFR1ekhyWlhHMTlLYWplclF4LTFvd3NFWC02V2NrOE9VQzNtX0R0RmJz?oc=5" target="_blank">US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug</a> <font color="#6f6f6f">Reuters</font>
U.S. cancer centers are urgently enrolling patients in an early access program for Revolution Medicines' experimental drug daraxonrasib, following its FDA-approved expanded access program on May 1, 2026.
Medscape reports on the challenges faced by U.S. cancer clinics in accessing Revolution Medicines' experimental drug daraxonrasib, highlighting the FDA's recent approval for expanded access.
Medscape discusses the urgency among U.S. cancer clinics to provide patients with access to Revolution Medicines' experimental drug daraxonrasib, following the FDA's approval for expanded access.
Medscape reports on the challenges faced by U.S. cancer clinics in accessing Revolution Medicines' experimental drug daraxonrasib, following the FDA's recent approval for expanded access.
Medscape discusses the urgency among U.S. cancer clinics to provide patients with access to Revolution Medicines' experimental drug daraxonrasib, following the FDA's approval for expanded access.
Yahoo News Malaysia reports on the challenges faced by U.S. cancer clinics in accessing Revolution Medicines' experimental drug daraxonrasib, following the FDA's recent approval for expanded access.
Similar Stories
Related coverage based on topic and tags
US FDA advisers endorse Grail cancer test's benefits in key vote - Reuters
US FDA advisers endorse Grail cancer test's benefits in key vote Reuters
September 23, 2026 at 11:03 PMUS FDA approves AbbVie's drug for Parkinson's disease - reuters.com
US FDA approves AbbVie's drug for Parkinson's disease reuters.com
September 25, 2026 at 10:57 PMMerck's drug for diabetes-related eye disease meets trial goal - Reuters
Merck's drug for diabetes-related eye disease meets trial goal Reuters
September 24, 2026 at 02:52 PMRoche's obesity drug boosts blood sugar control, drives 15.5% weight loss in mid-stage trial - Reuters
Roche's obesity drug boosts blood sugar control, drives 15.5% weight loss in mid-stage trial Reuters
September 22, 2026 at 11:25 AMWegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs - reuters.com
Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs reuters.com
September 21, 2026 at 05:02 AMCancer patient told she will get drug which could make her life longer
Patients in England with an incurable breast cancer can now access a life-extending drug on the NHS, two years after it was deemed too expensive by a health body.
September 17, 2026 at 05:28 AM